VCM
ABMD

Versant Capital Management’s Abiomed Inc ABMD Stock Holding History

Versant Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 1712
2022
Q3 		$0 Hold
1
– – ﹤0.01% 1736
2022
Q2 		$0 Buy
+1
New +$270 ﹤0.01% 1708
2019
Q1 		– Sell
-2
Closed – – 1799
2018
Q4 		$0 Hold
2
– – ﹤0.01% 1703
2018
Q3 		$0 Hold
2
– – ﹤0.01% 1698
2018
Q2 		$0 Hold
2
– – ﹤0.01% 1691
2018
Q1 		$0 Sell
2
-5
-71% -$1.27K ﹤0.01% 1709
2017
Q4 		$1K Hold
7
– – ﹤0.01% 1482
2017
Q3 		$1K Hold
7
– – ﹤0.01% 1394
2017
Q2 		$1K Sell
7
-2
-22% -$269 ﹤0.01% 1390
2017
Q1 		$1K Hold
9
– – ﹤0.01% 1391
2016
Q4 		$1K Hold
9
– – ﹤0.01% 1347
2016
Q3 		$1K Hold
9
– – ﹤0.01% 1337
2016
Q2 		$0 Hold
9
– – ﹤0.01% 1479
2016
Q1 		$0 Sell
9
-2
-18% -$169 ﹤0.01% 1493
2015
Q4 		$0 Buy
+11
New +$934 ﹤0.01% 1448

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Versant Capital Management's ABMD Position: Q4 2022 in Review

Versant Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1 share.

Versant Capital Management first reported a position in ABMD in Q4 2015 and held it in 15 quarters. The position peaked at $1K in Q4 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Versant Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Versant Capital Management sold 1 Abiomed Inc share in Q4 2022.
  • Versant Capital Management first reported a position in Abiomed Inc in Q4 2015 and held it in 15 quarters.
  • Versant Capital Management's Abiomed Inc position peaked at $1K in Q4 2017.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Versant Capital Management's 13F filing for Q4 2022, filed 25 Jan 2023.